IDARUCIZUMAB

1307 reported adverse events

Drug classes: Humanized Monoclonal Antibody Fragment [EPC]

These side effects are most commonly reported by patients taking IDARUCIZUMAB:

# Side effect Count
0 DEATH 155
1 HAEMORRHAGE 101
2 GASTROINTESTINAL HAEMORRHAGE 77
3 CEREBRAL HAEMORRHAGE 73
4 HAEMORRHAGE INTRACRANIAL 66
5 DRUG INEFFECTIVE 58
6 MULTIPLE ORGAN DYSFUNCTION SYNDROME 58
7 ACUTE KIDNEY INJURY 43
8 ISCHAEMIC STROKE 42
9 SEPSIS 42
See all common reactions for IDARUCIZUMAB

IDARUCIZUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 LIMB GIRTH INCREASED 1 0.1250
1 COAGULATION FACTOR INCREASED 5 0.0926
2 DECOMPRESSIVE CRANIECTOMY 1 0.0769
3 THROMBIN TIME ABNORMAL 3 0.0714
4 ANTICOAGULATION DRUG LEVEL INCREASED 11 0.0430
5 BASILAR ARTERY ANEURYSM 1 0.0385
6 PROCEDURAL SHOCK 1 0.0385
7 BASILAR ARTERY OCCLUSION 5 0.0362
8 BASAL GANGLIA HAEMATOMA 1 0.0345
9 SPLEEN SCAN ABNORMAL 1 0.0333
See all enriched reactions for IDARUCIZUMAB